Duygu Aydemir1,2*
Nuriye Nuray Ulusu1,2*- 1Koc University, School of Medicine, Department of Medical Biochemistry, Istanbul, Türkiye
- 2Koç University Research Center for Translational Medicine (KUTTAM), Istanbul, Türkiye
Introduction
Endocrine-disrupting chemicals (EDCs) dysregulate hormone metabolism via interfering with estrogen, thyroid, and nuclear receptors such as peroxisome proliferator-activated receptors alpha and gamma (PPARα, PPARγ). EDCs can be either natural or manufactured chemicals such as aromatic hydrocarbons (PHAs), polychlorinated biphenyls (PCBs), phthalates, pesticides, flame retardants, phenols, and toxic metals exerting adverse health effects on both humans and wildlife (1). People are exposed to EDCs daily via inhalation, dermal contact, and digestion since these chemicals are found in almost all industrial products, including pharmaceuticals, cosmetics, toys, food packaging, medical devices, households, and plastics (2). EDCs are metabolized by liver, kidney, intestine, and skin esterases after exposure and secreted via urine and bile; however, some of these chemicals remain without metabolization and accumulate in the body (3, 4).
EDCs exert toxic effects even at low concentrations since they contribute to several pathogeneses, including infertility, endocrine dysfunction, impaired hormone metabolism, cancer, metabolic syndrome, obesity, diabetes, cardiovascular dysfunction, and reproductive and neurological disorders (5). On the other hand, the female reproductive system is directly affected by EDCs, for instance, premature aging of ovaries, and impaired follicle formation, growth, and activity. Moreover, endometriosis, premature births, polycystic ovary syndrome, infertility, epigenetic changes in DNA methylation, genotoxicity, and prolonged puberty are adverse outcomes of EDCs exposure in females (5–7). Dysregulation in the female reproductive system can lead to premature and early menopause associated with an increased risk of cardiovascular diseases, dementia, osteoporosis, mood disorders, sexual dysfunction, and mortality (8).
Since oxidative stress causes impaired folliculogenesis, meiosis, and ovulation, it can contribute to premature and early menopause. Furthermore, antioxidant administration improves the quality of maternally aged oocytes, blastocyst formation, and oocyte aging, preventing or delaying ovarian dysfunction (9). EDCs and their metabolized products contribute to oxidative stress by binding PPARs in the ovary and other tissues; also, adverse effects of the EDCs have been reported on the female reproductive system (10). Therefore, this paper discussed the possible role of EDCs-induced oxidative stress in premature and early menopause.
The role of EDCs-induced oxidative stress in the female reproductive system
Oxidative stress is described by the imbalance between the antioxidant capacity and the production of reactive oxygen species (ROS) in the cell. Antioxidant defense in the cell is regulated via different antioxidant molecules and enzymes such as glutathione (GSH), glucose 6-phosphate dehydrogenase (G6PD), 6-phosphogluconate dehydrogenase (6-PGD), glutathione reductase (GR), glutathione s-transferase (GST), glutathione peroxidase (GPx), superoxide dismutase (SOD) and catalase (CAT). G6PD and 6-PGD take part in the pentose phosphate pathway (PPP), producing nicotinamide adenine dinucleotide phosphate (NADPH), which GR uses to convert oxidized glutathione (GSSG) to reduced glutathione (GSH). GSH/GSSG ratio is the primary biomarker for the oxidative stress, since increased levels of the GSSG indicate impaired redox balance in the cell. On the other hand, GPx and CAT detoxify hydrogen peroxide (H2O2), where SOD breaks down superoxide (O2.-) into water (H2O2) (11–13). Impaired oxidative stress status has been reported in the pathogenesis of various diseases such as cancer, diabetes, metabolic disorders, endocrine dysfunction, cardiovascular diseases, infertility, and neurological diseases, since ROS attack the DNA, lipid, proteins, and nucleic acids (14, 15). On the other hand, oxidative stress affects follicular fluid, oocyte maturation, ovarian steroid biosynthesis, ovulation, formation of blastocysts, implantation, embryogenesis, miscarriage, early birth, ovarian germ cell, and pre‐eclampsia, according to the literature (16).
Phthalates are a group of synthetic chemicals composed of alkyl diesters of phthalic acid found in almost all industrial products, such as cosmetics, toys, food wrappings, pharmaceuticals, households, and medical devices. Since phthalates are non-covalently bound to plastics, they can be easily released from the products to the environment (17, 18). Di(2-ethylhexyl) phthalate (DEHP), dibutyl phthalate (DBP), diethyl phthalate (DEP), and benzyl butyl phthalate
(BzBP) are metabolized into harmful byproducts such as monomethyl phthalate (MMP), monoethyl phthalate (MEP), monobutyl phthalate (MBP), mono(2-ethylhexyl) phthalate (MEHP), mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono(2-ethyl-5-oxohexyl) phthalate (MEOHP), monobenzyl phthalate (MBzP) and mono-n-octyl phthalate (MOP) in the body (19). DEHP and MEHP induce oxidative stress parameters, including 8-hydroxy-2′-deoxyguanosine (8-OHdG) and malondialdehyde (MDA) in the oocytes (20). Also, DEHP inhibits follicle growth and impairs endometrial cell function by inducing oxidative stress via decreased CAT, GPx (21) and SOD1 activity which is accepted as a biomarker for oocyte quality (22, 23). On the other hand, DEHP, MEHP, and DBP impair the cell cycle and induce apoptosis in the follicles by inducing oxidative stress, according to the literature (24).
Bisphenol A (BPA) is a plasticizer exerting endocrine-disrupting effects on the female reproductive system, such as reduced fertility, premature ovarian failure, inhibiting follicle growth, and decreased follicle counts (25). Moreover, 25 mg/kg/day BPA induced oxidative damage in the rat ovarian cells (26). BPA, bisphenol S (BPS), and bisphenol F (BPF) impaired the antioxidant status of bovine oocytes by reducing GPx and SOD activities (27). Pesticides are widely used chemicals in agriculture applications causing toxicity in the soil and water,
and other natural resources. Organophosphates and organochlorides cause the decreased estrous cycle, apoptosis in granulosa cells, clumping of oocytes, deletions in microvilli, inhibition of follicular growth, and damage in ovarian surface epithelium (OSE) via decreased GPx, SOD, CAT and GST activities in the rat and mice (28–30). Cadmium (Cd) is found in industrial products and agricultural activities, exerting endocrine-disrupting effects. Cd decreases antioxidant enzyme activities such as CAT and increases levels of MDA and H2O2 in the rat ovary. Also, Cd-induced oxidative stress cause reduced oocyte number and altered corpus luteum and oocyte tissue (31). On the other hand, persistent exposure to EDCs is associated with early menopause in women (32). Since different types of EDCs impair antioxidant capacity and increase oxidative stress in the female reproductive system, premature or early menopause can result from EDCs-induced oxidative stress.
Discussion
Menopause is a natural gradual process that occurs in females between the ages of 45-55, resulting from the age-dependent decline in fertility. On the other hand, premature ovarian insufficiency (POI) or premature ovarian failure, also known as early and premature menopause, is characterized by ovarian failure before age 40, affecting 1% of women (33, 34). Decreased estrogen, increased follicle-stimulating hormone (FSH), and luteinizing hormone (LH) are characteristics of menopause. Compared to pre-menopausal women, increased oxidative stress and decreased antioxidant capacity have been reported in menopausal and post-menopausal women (35). For instance, reduced levels of SOD, CAT, GPx, GSH, vitamin C, and vitamin E have been reported in post-menopausal women compared to pre-menopausal females (36, 37). On the other hand, decreased estrogen levels during menopause contribute to impaired redox balance in females since estrogen has antioxidant effects (38).
Enzyme deficiencies, genetic disorders, environmental toxins, metabolic dysfunction, chemotherapy, radiotherapy, autoimmune diseases, and psychological factors contribute to the POI pathogenesis, which can be explained by the ovarian injury resulting from oxidative stress-induced apoptosis, inflammation, accelerated aging and mitochondrial dysfunction. For instance, increased MDA and decreased SOD and GPx activities have been reported in the POI (39, 40). Exposure to the EDCs including BPA, chromium, lead, cadmium, isoprene, methoxychlor (MTX), benzo(a)pyrene (BaP), 2-bromopropane, 2,5-hexanedione, ethylene glycol methyl ether (EGME), hexachlorobenzene, mancozeb, dicofol, carbosulfan, 4-vinylcyclohexene (VCH), butadiene methylcholanthrene (3MC), 2,2-bis(bromomethyl)-1,3-propanediol (BMPB), hexabromocyclododecane and dimethylbenzantracene (DMBA) is directly associated with the POI according to the literature (39).
Increased levels of urinary phthalates are tightly associated with the POI and decreased estradiol levels (41). BPA, DEHP, MHP, dichlorodiphenyltrichloroethane (DDT), MTX, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), and bis-hydroxy methoxychlor (HPTE) exposure cause decreased estrogen and increased LH and testosterone contributing to the POI pathogenesis in the females (42). Three mechanisms, including follicle depletion, increased follicular recruitment, and impaired follicular maturation, are discussed as major contributors to EDCs-induced POI that all associated with the impaired oxidative stress metabolism (39). Enhanced oxidative stress or decreased antioxidant defense have adverse effects on both ovary and ovarian follicles. Dysfunction in the corpus luteum, altered follicular fluid, abnormal proliferation in the interstitial cells, apoptosis, decreased steroid synthesis in the granulosa cells, inhibition in the follicle growth and degeneration have been reported as oxidative stress-induced alteration in the ovary and ovarian follicles (43). On the other hand, antioxidant administration including melatonin, curcumin, resveratrol, quercetin, genistein, vitamin E, selenium, catalpol and hyperoside improved ovarian function and aging. For instance, SOD, CAT, GPx, GSH and thioredoxin reductase levels increased, whereas ROS, MDA, GSSG, 8-OHdG and H2O2 levels decreased upon antioxidant treatment (44).
Conclusion
EDCs have been found in almost all types of industrial products such as cosmetics, toys, medical devices, food wrappings and household exerting adverse health effects by interfering with the hormone metabolism. Although EDCs are metabolized in the liver, kidney, skin and intestines, some parts of them remain without metabolization and accumulate in the body causing metabolic disorders, infertility, reproductive dysfunction, diabetes, cancer and neurological disorders. EDCs-induced oxidative stress leads to the ovarian aging, PCOS, apoptosis in follicles, reduced follicle reserve, impaired follicle formation, growth, and activity which are directly correlated with POI pathogenesis. POI affects %1 women under age of 40 associated with increased risk of mortality, cardiovascular diseases, metabolic disorders and diabetes. EDCs exposure have been associated with POI induced by different mechanisms including follicle depletion, increased follicular recruitment, and impaired follicular maturation correlated with impaired oxidative stress metabolism. On the other hand, antioxidant treatment improved oxidative stress-induced alteration in the ovary and ovarian follicles. In conclusion, EDCs-induced oxidative stress may result in the early and premature menopause which can be improved or eased via antioxidant treatment.
Author contributions
DA and NU are responsible for the conceptualization and writing the manuscript. All authors contributed to the article and approved the submitted version.
Acknowledgments
The authors gratefully acknowledge the use of the services and facilities of the Koc University Research Center for Translational Medicine (KUTTAM), funded by the Presidency of Turkey, the Presidency of Strategy and Budget.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Author disclaimer
The content is solely the responsibility of the authors and does not necessarily represent the official views of the Presidency of Strategy and Budget.
References
1. Priya K, Setty M, Babu UV, Pai KSR. Implications of environmental toxicants on ovarian follicles: How it can adversely affect the female fertility? Environ Sci Pollut Res (2021) 28:67925–39. doi: 10.1007/s11356-021-16489-4
2. Milanović M, Đurić L, Milošević N, Milić N. Comprehensive insight into triclosan–from widespread occurrence to health outcomes. Environ Sci pollut Res (2021) 6:1–22. doi: 10.1007/s11356-021-17273-0
3. Aydemir D, Oztasci B, Barlas N, Ulusu NN. Influence of the butylparaben administration on the oxidative stress metabolism of liver, kidney and spleen. Turkish J Biochem (2020) 45:689–94. doi: 10.1515/tjb-2020-0048
4. Aydemir D, Öztaşcı B, Barlas N, Ulusu NN. Effects of butylparaben on antioxidant enzyme activities and histopathological changes in rat tissues. Arch Ind Hygiene Toxicol (2019) 70:315–24. doi: 10.2478/aiht-2019-70-3342
5. Kowalczyk A, Wrzecińska M, Czerniawska-Piątkowska E, Araújo JP, Cwynar P. Molecular consequences of the exposure to toxic substances for the endocrine system of females. Biomed Pharmacother (2022) 155:113730. doi: 10.1016/j.biopha.2022.113730
6. López-Rodríguez D, Aylwin CF, Delli V, Sevrin E, Campanile M, Martin M, et al. Multi- and transgenerational outcomes of an exposure to a mixture of endocrine-disrupting chemicals (EDCs) on puberty and maternal behavior in the female rat. Environ Health Perspect (2021) 129:087003. doi: 10.1289/EHP8795
7. Lucaccioni L, Trevisani V, Marrozzini L, Bertoncelli N, Predieri B, Lugli L, et al. Endocrine-disrupting chemicals and their effects during female puberty: A review of current evidence. Int J Mol Sci (2020) 21:2078. doi: 10.3390/ijms21062078
8. Faubion SS, Kuhle CL, Shuster LT, Rocca WA. Long-term health consequences of premature or early menopause and considerations for management. Climacteric (2015) 18:483–91. doi: 10.3109/13697137.2015.1020484
9. Camaioni A, Ucci MA, Campagnolo L, de Felici M, Klinger FG. The process of ovarian aging: It is not just about oocytes and granulosa cells. J Assist Reprod Genet (2022) 39:783–92. doi: 10.1007/s10815-022-02478-0
10. Komar CM. Peroxisome proliferator-activated receptors (PPARs) and ovarian function – implications for regulating steroidogenesis, differentiation, and tissue remodeling. Reprod Biol Endocrinol (2005) 3:41. doi: 10.1186/1477-7827-3-41
11. Aydemir D, Ulusu NN. Comment on the: Molecular mechanism of CAT and SOD activity change under MPA-CdTe quantum dots induced oxidative stress in the mouse primary hepatocytes (Spectrochim acta a mol biomol spectrosc. Spectrochim Acta A Mol Biomol Spectrosc (2020) 229:117792. doi: 10.1016/j.saa.2019.117792
12. Aydemir D, Hashemkhani M, Acar HY, Ulusu NN. In vitro interaction of glutathione s-transferase-pi enzyme with glutathione-coated silver sulfide quantum dots: A novel method for biodetection of glutathione s-transferase enzyme. Chem Biol Drug Des (2019) 94:2094–102. doi: 10.1111/cbdd.13614
13. Aydemir D, Hashemkhani M, Acar HY, Ulusu NN. Evaluation of the biocompatibility of the GSH-coated Ag2S quantum dots in vitro: A perfect example for the non-toxic optical probes. Mol Biol Rep (2020) 47:4117–29. doi: 10.1007/s11033-020-05522-3
14. Aydemir D, Sarayloo E, Ulusu NN. Rosiglitazone-induced changes in the oxidative stress metabolism and fatty acid composition in relation with trace element status in the primary adipocytes. J Med Biochem (2020) 39(3):267–75. doi: 10.2478/jomb-2019-0041
15. Aydemir D, Malik AN, Kulac I, Basak AN, Lazoglu I, Ulusu NN. Impact of the amyotrophic lateral sclerosis disease on the biomechanical properties and oxidative stress metabolism of the lung tissue correlated with the human mutant SOD1G93A protein accumulation. Front Bioeng Biotechnol (2022) 10:810243. doi: 10.3389/fbioe.2022.810243
16. Rk S, Agarwal A. Role of reactive oxygen species in gynecologic diseases. Reprod Med Biol (2004) 3:177–99. doi: 10.1111/j.1447-0578.2004.00068.x
17. Hongjun Y, Wenjun X, Qing L, Jingtao L, Hongwen Y, Zhaohua L. Distribution of phthalate esters in topsoil: a case study in the yellow river delta, China. Environ Monit Assess (2013) 185:8489–500. doi: 10.1007/s10661-013-3190-7
18. Bergé A, Cladière M, Gasperi J, Coursimault A, Tassin B, Moilleron R. Meta-analysis of environmental contamination by phthalates. Environ Sci pollut Res (2013) 20:8057–76. doi: 10.1007/s11356-013-1982-5
19. Yuan X-Q, Du Y-Y, Liu C, Guo N, Teng X-M, Hua X, et al. Phthalate metabolites and biomarkers of oxidative stress in the follicular fluid of women undergoing in vitro fertilization. Sci Total Environ (2020) 738:139834. doi: 10.1016/j.scitotenv.2020.139834
20. Pigini D, Caporossi L, Paci E, Capanna S, Viganò P, Alteri A, et al. Phthalate exposure and biomarkers of oxidation of nucleic acids: Results on couples attending a fertility center. Toxics (2022) 10:61. doi: 10.3390/toxics10020061
21. Cho YJ, bin PS, Han M. Di-(2-ethylhexyl)-phthalate induces oxidative stress in human endometrial stromal cells in vitro. Mol Cell Endocrinol (2015) 407:9–17. doi: 10.1016/j.mce.2015.03.003
22. Wang W, Craig ZR, Basavarajappa MS, Gupta RK, Flaws JA. Di (2-ethylhexyl) phthalate inhibits growth of mouse ovarian antral follicles through an oxidative stress pathway. Toxicol Appl Pharmacol (2012) 258:288–95. doi: 10.1016/j.taap.2011.11.008
23. Matos L, Stevenson D, Gomes F, Silva-Carvalho JL, Almeida H. Superoxide dismutase expression in human cumulus oophorus cells. Mol Hum Reprod (2009) 15:411–9. doi: 10.1093/molehr/gap034
24. Fletcher E, Santacruz-Márquez R, Mourikes V, Neff A, Laws M, Flaws J. Effects of phthalate mixtures on ovarian folliculogenesis and steroidogenesis. Toxics (2022) 10:251. doi: 10.3390/toxics10050251
25. Patel S, Zhou C, Rattan S, Flaws JA. Effects of endocrine-disrupting chemicals on the ovary. Biol Reprod (2015) 93(1):20. doi: 10.1095/biolreprod.115.130336
26. Avci B, Bahadir A, Tuncel OK, Bilgici B. Influence of α-tocopherol and α-lipoic acid on bisphenol-a-induced oxidative damage in liver and ovarian tissue of rats. Toxicol Ind Health (2016) 32:1381–90. doi: 10.1177/0748233714563433
27. Nguyen M, Sabry R, Davis OS, Favetta LA. Effects of BPA, BPS, and BPF on oxidative stress and antioxidant enzyme expression in bovine oocytes and spermatozoa. Genes (Basel) (2022) 13:142. doi: 10.3390/genes13010142
28. Koc ND, Kayhan FE, Sesal C, Muslu MN. Dose-dependent effects of endosulfan and malathion on adult wistar albino rat ovaries. Pakistan J Biol Sci (2009) 12:498–503. doi: 10.3923/pjbs.2009.498.503
29. Bhardwaj JK, Saraf P. Granulosa cell apoptosis by impairing antioxidant defense system and cellular integrity in caprine antral follicles post malathion exposure. Environ Toxicol (2016) 31:1944–54. doi: 10.1002/tox.22195
30. Bhardwaj JK, Mittal M, Saraf P, Kumari P. Pesticides induced oxidative stress and female infertility: A review. Toxin Rev (2020) 39:1–13. doi: 10.1080/15569543.2018.1474926
31. Nasiadek M, Danilewicz M, Klimczak M, Stragierowicz J, Kilanowicz A. Subchronic exposure to cadmium causes persistent changes in the reproductive system in female wistar rats. Oxid Med Cell Longev (2019) 2019:1–17. doi: 10.1155/2019/6490820
32. Grindler NM, Allsworth JE, Macones GA, Kannan K, Roehl KA, Cooper AR. Persistent organic pollutants and early menopause in U.S. women. PloS One (2015) 10:e0116057. doi: 10.1371/journal.pone.0116057
33. Okeke T, Anyaehie U, Ezenyeaku C. Premature menopause. Ann Med Health Sci Res (2013) 3:90–5. doi: 10.4103/2141-9248.109458
34. Agarwal A, Doshi S. The role of oxidative stress in menopause. J Midlife Health (2013) 4:140. doi: 10.4103/0976-7800.118990
35. Sekhon LH, Agarwal A. The menopause and oxidative stress. In: Totowa NJ, editor. Studies on women’s health. Humana Press (2013). p. 181–203. doi: 10.1007/978-1-62703-041-0_11
36. Ansar S, Alhefdhi T, Aleem AM. Status of trace elements and antioxidants in premenopausal and postmenopausal phase of life: a comparative study. Int J Clin Exp Med (2015) 8:19486–90.
37. Ramírez-Expósito MJ, Sánchez-López E, Cueto-Ureña C, Dueñas B, Carrera-González P, Navarro-Cecilia J, et al. Circulating oxidative stress parameters in pre- and post-menopausal healthy women and in women suffering from breast cancer treated or not with neoadjuvant chemotherapy. Exp Gerontol (2014) 58:34–42. doi: 10.1016/j.exger.2014.07.006
38. Bednarek-Tupikowska G, Tupikowski K, Bidzińska B, Bohdanowicz-Pawlak A, Antonowicz-Juchniewicz J, Kosowska B, et al. Serum lipid peroxides and total antioxidant status in postmenopausal women on hormone replacement therapy. Gynecological Endocrinol (2004) 19:57–63. doi: 10.1080/09513590412331272328
39. Béranger R, Hoffmann P, Christin-Maitre S, Bonneterre V. Occupational exposures to chemicals as a possible etiology in premature ovarian failure: A critical analysis of the literature. Reprod Toxicol (2012) 33:269–79. doi: 10.1016/j.reprotox.2012.01.002
40. Immediata V, Ronchetti C, Spadaro D, Cirillo F, Levi-Setti PE. Oxidative stress and human ovarian response–from somatic ovarian cells to oocytes damage: A clinical comprehensive narrative review. Antioxidants (2022) 11:1335. doi: 10.3390/antiox11071335
41. Cao M, Pan W, Shen X, Li C, Zhou J, Liu J. Urinary levels of phthalate metabolites in women associated with risk of premature ovarian failure and reproductive hormones. Chemosphere (2020) 242:125206. doi: 10.1016/j.chemosphere.2019.125206
42. Craig ZR, Wang W, Flaws JA. Endocrine-disrupting chemicals in ovarian function: effects on steroidogenesis, metabolism and nuclear receptor signaling. REPRODUCTION (2011) 142:633–46. doi: 10.1530/REP-11-0136
43. Yan F, Zhao Q, Li Y, Zheng Z, Kong X, Shu C, et al. The role of oxidative stress in ovarian aging: a review. J Ovarian Res (2022) 15:100. doi: 10.1186/s13048-022-01032-x
Keywords: oxidative stress, premature menopause, endocrine disruptors, early menopause, antioxidant status
Citation: Aydemir D and Ulusu NN (2023) The possible role of the endocrine disrupting chemicals on the premature and early menopause associated with the altered oxidative stress metabolism. Front. Endocrinol. 14:1081704. doi: 10.3389/fendo.2023.1081704
Received: 27 October 2022; Accepted: 06 February 2023;
Published: 14 February 2023.
Edited by:
Julianna Thuroczy, National Public Health and Medical Officer Service, United KingdomReviewed by:
Müfide Aydoğan Ahbab, University of Health Sciences, TürkiyeCopyright © 2023 Aydemir and Ulusu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Duygu Aydemir, ZGF5ZGVtaXIxNkBrdS5lZHUudHI=; Nuriye Nuray Ulusu, bnVsdXN1QGt1LmVkdS50cg==